These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 8236097
1. Neointimal proliferation: the role of basic FGF on vascular smooth muscle cell proliferation. Reidy MA. Thromb Haemost; 1993 Jul 01; 70(1):172-6. PubMed ID: 8236097 [No Abstract] [Full Text] [Related]
5. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. Camozzi M, Zacchigna S, Rusnati M, Coltrini D, Ramirez-Correa G, Bottazzi B, Mantovani A, Giacca M, Presta M. Arterioscler Thromb Vasc Biol; 2005 Sep 15; 25(9):1837-42. PubMed ID: 16020751 [Abstract] [Full Text] [Related]
6. TAS-301, an inhibitor of smooth muscle cell migration and proliferation, inhibits intimal thickening after balloon injury to rat carotid arteries. Muranaka Y, Yamasaki Y, Nozawa Y, Terakawa H, Tanahashi Y, Oda N, Satoh A, Asao T, Miyake H, Matsuura N. J Pharmacol Exp Ther; 1998 Jun 15; 285(3):1280-6. PubMed ID: 9618434 [Abstract] [Full Text] [Related]
7. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation. Francis DJ, Parish CR, McGarry M, Santiago FS, Lowe HC, Brown KJ, Bingley JA, Hayward IP, Cowden WB, Campbell JH, Campbell GR, Chesterman CN, Khachigian LM. Circ Res; 2003 May 02; 92(8):e70-7. PubMed ID: 12690039 [Abstract] [Full Text] [Related]
8. Inhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran. Wiernicki TR, Bean JS, Dell C, Williams A, Wood D, Kauffman RF, Singh JP. J Pharmacol Exp Ther; 1996 Sep 02; 278(3):1452-9. PubMed ID: 8819533 [Abstract] [Full Text] [Related]
9. Transient reexpression of an embryonic autonomous growth phenotype by adult carotid artery smooth muscle cells after vascular injury. Weiser-Evans MC, Quinn BE, Burkard MR, Stenmark KR. J Cell Physiol; 2000 Jan 02; 182(1):12-23. PubMed ID: 10567912 [Abstract] [Full Text] [Related]
10. Endothelial control of vascular smooth muscle proliferation in an organ culture of human saphenous vein. Soyombo AA, Thurston VJ, Newby AC. Eur Heart J; 1993 Nov 02; 14 Suppl I():201-6. PubMed ID: 8293778 [Abstract] [Full Text] [Related]
11. Role of basic fibroblast growth factor and platelet-derived growth factor (B-chain) in neointima formation after arterial injury. Lindner V. Z Kardiol; 1995 Nov 02; 84 Suppl 4():137-44. PubMed ID: 8585266 [Abstract] [Full Text] [Related]
12. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor. Gennaro G, Ménard C, Michaud SE, Deblois D, Rivard A. Circulation; 2004 Nov 23; 110(21):3367-71. PubMed ID: 15520324 [Abstract] [Full Text] [Related]
13. Basic fibroblast growth factor and myointimal hyperplasia after experimental polytetrafluoroethylene arterial grafting. Sterpetti AV, Cucina A, Randone B, Graziano P, Stipa F, Corvino V, Cavallaro G, Palmieri I, Amato D, Polistena A, Cavallaro A. Eur J Surg; 1999 Aug 23; 165(8):772-6. PubMed ID: 10494644 [Abstract] [Full Text] [Related]
14. Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries. Shinohara M, Kawashima S, Yamashita T, Takaya T, Toh R, Ishida T, Ueyama T, Inoue N, Hirata K, Yokoyama M. Cardiovasc Res; 2005 Nov 01; 68(2):249-58. PubMed ID: 16039635 [Abstract] [Full Text] [Related]
15. Boundary layer infusion of basic fibroblast growth factor accelerates intimal hyperplasia in endarterectomized canine artery. Chen C, Li J, Mattar SG, Pierce GF, Aukerman L, Hanson SR, Lumsden AB. J Surg Res; 1997 May 01; 69(2):300-6. PubMed ID: 9224397 [Abstract] [Full Text] [Related]
16. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Matter CM, Chadjichristos CE, Meier P, von Lukowicz T, Lohmann C, Schuler PK, Zhang D, Odermatt B, Hofmann E, Brunner T, Kwak BR, Lüscher TF. Circulation; 2006 Apr 18; 113(15):1879-87. PubMed ID: 16606788 [Abstract] [Full Text] [Related]
17. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Sakata Y, Xiang F, Chen Z, Kiriyama Y, Kamei CN, Simon DI, Chin MT. Arterioscler Thromb Vasc Biol; 2004 Nov 18; 24(11):2069-74. PubMed ID: 15345511 [Abstract] [Full Text] [Related]
18. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Maffia P, Grassia G, Di Meglio P, Carnuccio R, Berrino L, Garside P, Ianaro A, Ialenti A. Circulation; 2006 Aug 01; 114(5):430-7. PubMed ID: 16864728 [Abstract] [Full Text] [Related]
19. Basic FGF and growth of arterial cells. Reidy MA, Lindner V. Ann N Y Acad Sci; 1991 Aug 01; 638():290-9. PubMed ID: 1785807 [No Abstract] [Full Text] [Related]
20. Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Deguchi J, Namba T, Hamada H, Nakaoka T, Abe J, Sato O, Miyata T, Makuuchi M, Kurokawa K, Takuwa Y. Gene Ther; 1999 Jun 01; 6(6):956-65. PubMed ID: 10455397 [Abstract] [Full Text] [Related] Page: [Next] [New Search]